New Search

If you are not happy with the results below please do another search

2034 search results for:

512

Monocyte distribution width: new biomarker for sepsis diagnosis

by Dr Elena Sukhacheva Early diagnosis and fast treatment of sepsis is crucial for obtaining the best outcome possible for the patient. However, diagnosis is not easy clinically and the complexity of the condition means that there is not an obvious individual biomarker for it. However, research in recent years has shown that monocyte distribution […]

513

Happy Anniversary ELITechGroup Biomedical Systems

ELITechGroup Biomedical Systems is celebrating its 50th anniversary this year. CLI caught up with Bryce McEuen (Managing Director and Business Unit Manager, Biomedical Systems) to discover more about the company’s story over the last 50 years. Congratulations on the 50th anniversary of ELITechGroup Biomedical Systems. What happened in 1970 to bring the business into existence? […]

514

Thermo Fisher Scientific collaborates with AstraZeneca and University of Nebraska Medical Center for biomarker discovery

Thermo Fisher Scientific has established new collaborations of the Thermo Fisher Precision Medicine Science Center (PMSC) with AstraZeneca and the University of Nebraska Medical Center as part of its ongoing development of innovative solutions for unmet needs in clinical biomarker discovery. The new alliances strengthen the PMSC’s mission of creating standardized workflows with pharma and […]

515

Roche acquires Enterprise Therapeutics’ First-in-Class TMEM16A potentiator program for treatment of cystic fibrosis

Roche has acquired Enterprise Therapeutics novel TMEM16A potentiator portfolio, which will be developed by Genentech, a member of the Roche Group. The portfolio includes ETD002 which recently entered Phase 1 trials. Enterprise’s shareholders received an upfront payment of £75 million and are eligible to receive additional contingent payments, to be made based on the achievement […]

516

New indicator diseases reveal hidden HIV

Today, heterosexuals in Europe are at particular risk of carrying HIV for so long that they remain undiagnosed until their immune system starts to fail and they become ill. An international study under the leadership of the HIV in Europe initiative has now revealed that a number of diseases, including herpes zoster and certain forms […]

518

Researchers find malignancy-risk gene signature for early-stage non-small cell lung cancer

A malignancy-risk gene signature developed for breast cancer has been found to have predictive and prognostic value for patients with early stage non-small cell lung cancer. The advancement was made by researchers at Moffitt Cancer Center in Tampa. According to corresponding author Dung-Tsa Chen, Ph.D., associate member with the Moffitt Biostatistics program, non-small cell lung […]

519

Cervical screening programme saves lives in more ways than one

Regular cervical screening saves lives not only by discovering pre-cursors to cervical cancer before they become invasive – but also by improving the chances of successful treatment in cases where invasive cancer could not be prevented. ‘We found that women who die of cervical cancer have usually not been screened for a long time,’ says […]